Literature DB >> 26578757

Kinetics methods for clinical epidemiology problems.

Alexandru Dan Corlan1, John Ross2.   

Abstract

Calculating the probability of each possible outcome for a patient at any time in the future is currently possible only in the simplest cases: short-term prediction in acute diseases of otherwise healthy persons. This problem is to some extent analogous to predicting the concentrations of species in a reactor when knowing initial concentrations and after examining reaction rates at the individual molecule level. The existing theoretical framework behind predicting contagion and the immediate outcome of acute diseases in previously healthy individuals is largely analogous to deterministic kinetics of chemical systems consisting of one or a few reactions. We show that current statistical models commonly used in chronic disease epidemiology correspond to simple stochastic treatment of single reaction systems. The general problem corresponds to stochastic kinetics of complex reaction systems. We attempt to formulate epidemiologic problems related to chronic diseases in chemical kinetics terms. We review methods that may be adapted for use in epidemiology. We show that some reactions cannot fit into the mass-action law paradigm and solutions to these systems would frequently exhibit an antiportfolio effect. We provide a complete example application of stochastic kinetics modeling for a deductive meta-analysis of two papers on atrial fibrillation incidence, prevalence, and mortality.

Entities:  

Keywords:  chemical kinetics; epidemiology; noncommunicable disease; paradigm; stochastic model

Mesh:

Year:  2015        PMID: 26578757      PMCID: PMC4655575          DOI: 10.1073/pnas.1510927112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  The epidemiological revolution of the 20th century.

Authors:  Silvio De Flora; Alberto Quaglia; Carlo Bennicelli; Marina Vercelli
Journal:  FASEB J       Date:  2005-06       Impact factor: 5.191

2.  Incremental parameter evaluation from incomplete data with application to the population pharmacology of anticoagulants.

Authors:  Marcel O Vlad; Alexandru Dan Corlan; Federico Morán; Peter Oefner; John Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-19       Impact factor: 11.205

3.  On anti-portfolio effects in science and technology with application to reaction kinetics, chemical synthesis, and molecular biology.

Authors:  Marcel O Vlad; Alexandru Dan Corlan; Vlad T Popa; John Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

4.  Molecular crowding on the cell surface.

Authors:  T A Ryan; J Myers; D Holowka; B Baird; W W Webb
Journal:  Science       Date:  1988-01-01       Impact factor: 47.728

5.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

6.  Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.

Authors:  Jonathan P Piccini; Susanna R Stevens; YuChiao Chang; Daniel E Singer; Yuliya Lokhnygina; Alan S Go; Manesh R Patel; Kenneth W Mahaffey; Jonathan L Halperin; Günter Breithardt; Graeme J Hankey; Werner Hacke; Richard C Becker; Christopher C Nessel; Keith A A Fox; Robert M Califf
Journal:  Circulation       Date:  2012-12-03       Impact factor: 29.690

7.  An analysis of age-prevalence data by catalytic models. A contribution to the study of bilharziasis.

Authors:  N G Hairston
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

8.  Disease progression and survival in ALS: first multi-state model approach.

Authors:  Juan Gil; Pierre-Marie Preux; Ahmadou Alioum; Carlos Ketzoian; Jean-Claude Desport; Michel Druet-Cabanac; Philippe Couratier
Journal:  Amyotroph Lateral Scler       Date:  2007-08

9.  Applications of continuous time hidden Markov models to the study of misclassified disease outcomes.

Authors:  Alexandre Bureau; Stephen Shiboski; James P Hughes
Journal:  Stat Med       Date:  2003-02-15       Impact factor: 2.373

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  1 in total

1.  COVID-19: Mechanistic model calibration subject to active and varying non-pharmaceutical interventions.

Authors:  Mark J Willis; Allen Wright; Victoria Bramfitt; Victor Hugo Grisales Díaz
Journal:  Chem Eng Sci       Date:  2020-11-26       Impact factor: 4.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.